Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis
出版年份 2020 全文链接
标题
Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis
作者
关键词
-
出版物
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-11-19
DOI
10.1007/s10557-020-07108-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Stroke Prophylaxis in Patients with Atrial Fibrillation and End-Stage Renal Disease
- (2020) Martin van Zyl et al. Journal of Clinical Medicine
- Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease
- (2020) Matthew R. Weir et al. AMERICAN HEART JOURNAL
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Effectiveness and Safety of Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation Patients with Severe Kidney Disease or Undergoing Hemodialysis
- (2019) Craig I. Coleman et al. AMERICAN JOURNAL OF MEDICINE
- Taiwan’s National Health Insurance Research Database: past and future
- (2019) Cheng-Yang Hsieh et al. Clinical Epidemiology
- Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease
- (2018) Joseph H. Schafer et al. ANNALS OF PHARMACOTHERAPY
- Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States
- (2018) Konstantinos C. Siontis et al. CIRCULATION
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Antithrombotic Therapy for Atrial Fibrillation
- (2018) Gregory Y.H. Lip et al. CHEST
- Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study
- (2018) Holger Reinecke et al. BMJ Open
- Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy
- (2017) Peter W. Santos et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients
- (2017) Thomas A. Mavrakanas et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment
- (2017) Brooke E. Stanton et al. PHARMACOTHERAPY
- Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF
- (2016) Kevin E. Chan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors
- (2016) S. U. Nigwekar et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
- (2016) Chern-En Chiang et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
- (2015) K. E. Chan et al. CIRCULATION
- Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis
- (2015) Xiaoli Wang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A tutorial on propensity score estimation for multiple treatments using generalized boosted models
- (2013) Daniel F. McCaffrey et al. STATISTICS IN MEDICINE
- The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments
- (2013) Peter C. Austin STATISTICS IN MEDICINE
- Vascular calcification: The price to pay for anticoagulation therapy with vitamin K-antagonists
- (2012) Martijn L.L. Chatrou et al. BLOOD REVIEWS
- The Global Burden of Atrial Fibrillation and Stroke
- (2012) Gregory Y.H. Lip et al. CHEST
- Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
- (2011) Charles A. Herzog et al. KIDNEY INTERNATIONAL
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- (2011) Peter C. Austin MULTIVARIATE BEHAVIORAL RESEARCH
- Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2-VASc risk stratification scores
- (2010) B. Pamukcu et al. AGE AND AGEING
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Warfarin in haemodialysis patients with atrial fibrillation: what benefit?
- (2010) F. Yang et al. EUROPACE
- Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy
- (2010) Volker Wizemann et al. KIDNEY INTERNATIONAL
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
- Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation
- (2009) K. E. Chan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
- (2009) Peter C. Austin STATISTICS IN MEDICINE
- All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan
- (2008) Chi Pang Wen et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started